World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02266641
Date of registration: 13/10/2014
Prospective Registration: No
Primary sponsor: National Taiwan University Hospital
Public title: Parental One-carbon Folate and Choline Nutrition Modulates Risk of Off-spring Cancer Development: Human Cohort Study
Scientific title: Parental One-carbon Folate and Choline Nutrition Modulates Risk of Off-spring Cancer Development: Human Cohort Study
Date of first enrolment: October 2014
Target sample size: 118
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02266641
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Taiwan
Contacts
Name:     Rwei-Fen S. Huang
Address: 
Telephone:
Email:
Affiliation:  Fu Jen Catholic University
Name:     Kuang-Ta Huang
Address: 
Telephone:
Email:
Affiliation:  Hueishin women and children clinic
Name:     Chien-Nan Lee
Address: 
Telephone:
Email:
Affiliation:  National Taiwan University Hospital
Name:     Chin-Pao Cheng
Address: 
Telephone:
Email:
Affiliation:  National Taiwan University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Healthy pregnant women aged 21-40 years with first and single fetal pregnancy

2. Healthy pregnant women aged 21-40 years with first and single fetal pregnancy and
lineal relative had diabetes

3. Healthy pregnant women aged 21-40 years with first and single fetal pregnancy and
lineal relative had cancer

4. Healthy pregnant women, who are overweight/obesity (pre-pregnancy BMI?24 kg/m2) or her
lineal relative with overweight/obesity, aged 21-40 years with first and single fetal
pregnancy.

Exclusion Criteria:

- Pregnant women who had heart disease, kidney disease, cancer or accepting medical
treatment



Age minimum: 21 Years
Age maximum: 40 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Off-spring Cancer Risk
Intervention(s)
Behavioral: nutrition counseling
Dietary Supplement: multivitamin supplement
Primary Outcome(s)
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the first trimester visit of pregnancy [Time Frame: 7-10 weeks]
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the second trimester of pregnancy [Time Frame: 20-28 weeks]
Assessment of maternal one-carbon nutrient (folate, choline, betaine, Vitamine B12) intake at the third trimester of pregnancy [Time Frame: 36-37 weeks]
Secondary Outcome(s)
Measure maternal blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.) [Time Frame: 24-28 weeks]
Measure maternal and cord blood and placenta tissues MTHFR C677T genotypes [Time Frame: 37-40 weeks]
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine (8-OHdG) and inflammatory markers (TNF-a, NF-?B, Interleukin, etc.) [Time Frame: 7-10 weeks]
Measure maternal blood, cord blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.) [Time Frame: 37-40 weeks]
Measure maternal blood and urine biochemistry (folate, choline, betaine, homocysteine, Vitamine B2, Vitamine B6, Vitamine B12, etc.) [Time Frame: 7-10 weeks]
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine (8-OHdG) and inflammatory markers (TNF-a, NF-?B, Interleukin, etc.) [Time Frame: 37-40 weeks]
Measure maternal blood imprinted genes (sonic hedgehog, insulin-like growth factor 2, long interspersed nuclear element 1, etc.) DNA methylation status, DNA 8-Hydroxydeoxyguanosine and inflammatory markers (TNF-a, NF-?B, Interleukin, etc.) [Time Frame: 24-28 weeks]
Secondary ID(s)
201401034RINB
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history